(3R,4R)-3-methyl-4-(trifluoromethyl)pyrrolidine hydrochloride, 98%, 500mg

(E)-2-(2-(cyclohex-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 250mg

3,4,5-TRIS(DODECYLOXY)BENZOIC ACID, 95%, 25g

1-{1-[(4-Fluorophenyl)methyl]-1H-pyrazol-5-yl}methanamine hydrochloride, 1g

ROTI®Nanoquant, 50 ml, 200 assays (cuvettes)

4-(1H-Imidazol-4-yl)aniline, 95.0%, 1g

4-(3-Methoxyphenyl)oxazole, 95+%, 100mg

4-(Pyrrolidine-1-sulfonyl)-benzoic acid, 10g

1,3-Diiodobenzene, 99.0%, 100g

(2-Methyloxazol-4-yl)methanamine, 97.0%, 250mg

1-(2,5-Dihydro-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one, 97%, 5g

1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone, 95.0%, 25mg

1-(2-Hydroxy-5-(trifluoromethyl)phenyl)ethanone, 95.0%, 250mg